Cao Xueyuan

Dr. Cao Xueyuan


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
TZTao Zhang
Tao Zhang
YGYuchen Guo
Yuchen Guo
BQBinxu Qiu
Binxu Qiu
XDXianyu Dai
Xianyu Dai
YWYifei Wang
Yifei Wang
CXCao Xueyuan
Cao Xueyuan
Background: Colorectal cancer (CRC) is a common malignancy with notable recent shifts in its burden distribution. Current data on CRC burden can guide screening, early detection, and treatment strategies for efficient resource allocation.Methods: This study utilized data from the latest Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study. Initially, a series of descriptive statistics were performed on the incident cases, deaths, disability-adjusted life years (DALYs), and age-standardized rates (ASRs) of CRC. Percentage changes and average annual percentage changes (AAPC) were then calculated to understand the trends in CRC disease burden. Decomposition and frontier analyses were conducted, and finally, the Bayesian age-period-cohort (BAPC) model was used to predict changes in ASRs up to 2040.Results: The GBD 2021 estimates indicate a significant increase in the global incident cases, deaths, and DALYs of CRC from 1990 to 2021. The age-standardized incidence rate (ASIR) increased (AAPC: 0.2), while the age-standardized mortality rate (ASMR) (AAPC: -0.72) and age-standardized DALYs rate (AAPC: -0.73) decreased. Males bore a higher disease burden than females, though the trends in disease burden changes were similar for both sexes. Although developed regions had higher incident cases, deaths, and DALYs, they showed more significant declines in ASRs. Decomposition analysis revealed that population growth and aging were the primary drivers of the increased disease burden. Frontier analysis showed that as the Socio-demographic Index increased, the disparity in CRC ASRs among countries widened, with developed regions having greater potential to reduce these rates. The By 2040, the BAPC model projects significant declines in global ASMR and age-standardized DALYs rates, while ASIR is expected to decrease in females but increase in males and across both sexes.Conclusion: CRC remains a significant public health issue with regional and gender differences, necessitating region- and population-specific prevention strategies.

1 December 2018 in Medicine
Verified
Journal Article
Open access
YPYu-Chen Pan
Yu-Chen Pan
ZJZhi-Fang Jia
Zhi-Fang Jia
DCDong-Hui Cao
Dong-Hui Cao
YWYan-Hua Wu
Yan-Hua Wu
JJJing Jiang
Jing Jiang
CXCao Xueyuan
Cao Xueyuan
Preoperational hemogram parameters have been reported to be associated with the prognosis of several types of cancers. This study aimed to investigate the prognostic value of hematological parameters in gastric cancer in a Chinese population. A total of 870 gastric cancer patients who underwent radical tumorectomy were recruited from January 2008 to December 2012. Preoperative hematological parameters were recorded and dichotomized by time-dependent receiver operating characteristic curves. The survival curves of patients stratified by each hematological parameter were plotted by the Kaplan–Meier method and compared by log-rank test. Multivariate Cox proportional hazards models were used to select parameters independently correlated with prognosis. The median age of the patients was 60 years. The median follow-up time was 59.9 months, and the 5-year survival rate was 56.4%. Results from the univariate analyses showed that low lymphocyte count ( 0.55), low lymphocyte-to-white blood cell ratio (LWR < 0.23), low lymphocyte-to-monocyte ratio (LMR < 5.43), high neutrophil-to-lymphocyte ratio (NLR > 1.44), and high platelet-to-lymphocyte ratio (PLR > 115) were associated with poor survival of gastric cancer patients. Multivariate analysis showed that low LMR (HR: 1.49, 95% CI: 1.17–1.89, P = .001) was the only hematological factor independently predicting poor survival. These results indicate that preoperational LMR is an independent prognostic factor for patients with resectable gastric cancer.

29 January 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
DLDongming Li
Dongming Li
DCDonghui Cao
Donghui Cao
YSYuanlin Sun
Yuanlin Sun
YCYingnan Cui
Yingnan Cui
YZYangyu Zhang
Yangyu Zhang
CXCao Xueyuan
Cao Xueyuan
Cancer, a disease that modern medicine has not fully understood and conquered, with its high incidence and mortality, deprives countless patients of health and even life. According to global cancer statistics, there were an estimated 19.3 million new cancer cases and nearly 10 million cancer deaths in 2020, with the age-standardized incidence and mortality rates of 201.0 and 100.7 per 100,000, respectively. Although remarkable advancements have been made in therapeutic strategies recently, the overall prognosis of cancer patients remains not optimistic. Consequently, there are still many severe challenges to be faced and difficult problems to be solved in cancer therapy today. Epigallocatechin gallate (EGCG), a natural polyphenol extracted from tea leaves, has received much attention for its antitumor effects. Accumulating investigations have confirmed that EGCG can inhibit tumorigenesis and progression by triggering apoptosis, suppressing proliferation, invasion, and migration, altering tumor epigenetic modification, and overcoming chemotherapy resistance. Nevertheless, its regulatory roles and biomolecular mechanisms in the immune microenvironment, metabolic microenvironment, and immunotherapy remain obscure. In this article, we summarized the most recent updates about the effects of EGCG on tumor microenvironment (TME), metabolic reprogramming, and anti-cancer immunotherapy. The results demonstrated EGCG can promote the anti-cancer immune response of cytotoxic lymphocytes and dendritic cells (DCs), attenuate the immunosuppression of myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs), and inhibit the tumor-promoting functions of tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), and various stromal cells including cancer-associated fibroblasts (CAFs), endothelial cells (ECs), stellate cells, and mesenchymal stem/stromal cells (MSCs). Additionally, EGCG can suppress multiple metabolic reprogramming pathways, including glucose uptake, aerobic glycolysis, glutamine metabolism, fatty acid anabolism, and nucleotide synthesis. Finally, EGCG, as an immunomodulator and immune checkpoint blockade, can enhance immunotherapeutic efficacy and may be a promising candidate for antitumor immunotherapy. In conclusion, EGCG plays versatile regulatory roles in TME and metabolic reprogramming, which provides novel insights and combined therapeutic strategies for cancer immunotherapy.

4 October 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
DCDonghui Cao
Donghui Cao
ZJZhifang Jia
Zhifang Jia
LYLili You
Lili You
YWYanhua Wu
Yanhua Wu
ZHZhen Hou
Zhen Hou
CXCao Xueyuan
Cao Xueyuan
18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling 18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling

8 June 2016 in Future Oncology
Verified
Journal Article
Closed access
JJJing Jiang
Jing Jiang
ZJZhi-Fang Jia
Zhi-Fang Jia
DCDong-Hui Cao
Dong-Hui Cao
YWYan-Hua Wu
Yan-Hua Wu
ZSZhi-Wei Sun
Zhi-Wei Sun
CXCao Xueyuan
Cao Xueyuan
Aim: Single nucleotide polymorphisms in miRNA-coding region may be involved in the development or progression of gastric cancer (GC). Materials & methods: Six SNPs (miR-146a rs2910164, miR-196a2 rs11614913, miR-27a rs895819, miR-423 rs6505162, miR-608 rs4919510, miR-149 rs2292832) were genotyped in 898 histologically confirmed GC cases and 992 controls in this hospital-based case–control study. Results: The G/G genotype of rs2910164 was associated with reduced risk of GC (odds ratio: 0.76, 95% CI: 0.60–0.97; p = 0.024). Meanwhile, in 838 GC cases receiving radical tumorectomy, cases bearing the G/G genotype of rs2910164 had shorter survival time comparing to cases with C/C or C/G genotype (hazard ratio: 1.36, 95% CI: 1.04–1.78, p = 0.023). Conclusion: rs2910164 of miR-146a is associated with GC.

22 February 2025 in Preventive Medicine Reports
Verified
Journal Article
Open access
SWShuai Wang
Shuai Wang
TZTao Zhang
Tao Zhang
DLDongming Li
Dongming Li
CXCao Xueyuan
Cao Xueyuan
Peptic ulcer disease (PUD) remains a significant global health challenge, with its prevalence generally declining due to advances in healthcare and reduction in key risk factors. However, smoking continues to be a major contributor to the burden of PUD. This study analyzes the temporal and spatial patterns of PUD burden attributable to smoking globally from 1990 to 2021, providing insights for public health interventions. Utilizing data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 database, we assessed deaths, disability-adjusted life years (DALYs), age-standardized mortality rate (ASMR), and age-standardized DALY rate (ASDR). Trends from 1990 to 2021 were evaluated using average annual percentage change (AAPC), and predictive analyses performed to understand past and future patterns. In 2021, 29,390 deaths and 816,999 DALYs were caused by PUD attributable to smoking worldwide. From 1990 to 2021, deaths, DALYs, ASMR (AAPC: -4.05), and ASDR (AAPC: -4.18) showed significant declines globally. Males experienced a higher burden than females across all metrics. At the national and regional levels, low and low-middle socio-demographic index (SDI) areas exhibited higher ASMR and ASDR than high-SDI regions, with East Asia, South Asia, and Southeast Asia contributing the highest burden. Future projections indicate a continued decline in the burden of PUD attributable to smoking over the next decade. Despite global declines in the burden of PUD attributable to smoking, substantial disparities persist, particularly in underdeveloped regions. Focused anti-smoking policies and targeted resource allocation are necessary to reduce the disease burden and address regional inequalities.